IP Library Granted Patent US 8,066,733
Granted Patent B2
US 8,066,733 · App. 12/338,731 · Granted Nov 29, 2011

Inverting occlusion devices, methods, and systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,066,733
App. No.
12/338,731
Granted
Nov 29, 2011
Kind
B2
Abstract

Described are devices, methods and systems useful for achieving occlusion of vascular vessels. Percutaneous procedures can be used to occlude and obliterate the greater saphenous vein, for example in the treatment of varicose vein condition caused by venous reflux. Certain embodiments encompass the percutaneous delivery of an occlusion device inverted within a cannula, its deployment and filling, so as to occlude or obliterate a portion of a vascular vessel.

Claims (30)

1. A medical kit for occluding a portion of the vasculature, comprising:

a cannulated device having a distal end and a lumen;

a balloon having a proximal end and a distal end and including a balloon wall comprising an isolated layer of a remodelable extracellular matrix material isolated from a biological tissue source and containing native crosslinks from the biological tissue source, the isolated layer of remodelable extracellular matrix material being effective upon implantation to induce cellular invasion and ingrowth into the balloon wall so that the balloon wall becomes remodeled with patient tissue, wherein said proximal balloon end is attached to the distal end of the cannulated device and at least a portion of said balloon, is received within the lumen of the cannulated device, the proximal balloon end being detachable from the distal end of the cannulated device inside the vasculature; and

a sheath configured for slidably receiving the cannulated device and balloon.

2. The medical kit of claim 1 , wherein said proximal end of said balloon is releasably attached to an exterior surface of the cannulated device.

3. A medical device for occluding a bodily lumen, comprising:

a cannulated device having a lumen, a proximal end, and a distal end;

a balloon releasably coupled to said cannulated device and including a balloon wall comprising an isolated layer of a remodelable extracellular matrix material isolated from a biological tissue source and containing native crosslinks from the biological tissue source, the isolated layer of remodelable extracellular matrix material being effective upon implantation to induce cellular invasion and ingrowth into the balloon wall so that the balloon wall becomes remodeled with patient tissue, wherein at least a portion of said balloon is inverted and an interior of said balloon is in communication with said lumen of said cannulated device; and

a flowable material located in the interior of said balloon, the flowable material comprising a remodelable extracellular matrix fill material that is effective to induce cellular invasion and ingrowth into the remodelable extracellular matrix fill material following implantation so that the remodelable extracellular matrix fill material becomes remodeled with patient tissue.

4. The medical device of claim 3 , wherein at least a portion of said balloon is inverted within said lumen.

5. The medical device of claim 3 , wherein said cannulated device further comprises an inner tube, thereby creating an annular region within the cannulated device.

6. The medical device of claim 5 , wherein said balloon comprises a double walled balloon.

7. The medical device of claim 3 , wherein the cannulated device further comprises an external wire guide port.

8. A medical device for occluding a bodily lumen, comprising:

a cannulated device; and

a balloon releasably coupled to said cannulated device, said balloon having a proximal end and a distal end and including a balloon wall comprising an isolated layer of a naturally-derived and non-reconstituted remodelable extracellular matrix material isolated from a biological tissue source, the isolated layer of remodelable extracellular matrix material being effective upon implantation to induce cellular invasion and ingrowth into the balloon wall so that the balloon wall becomes remodeled with patient tissue, wherein at least a portion of said balloon occupies an inverted position.

9. The medical device of claim 8 , wherein said isolated layer of remodelable extracellular matrix material retains bioactive components native to said biological tissue source.

10. The medical device of claim 9 , wherein said balloon is at least about 10 cm in length.

11. A medical product, comprising:

a cannulated device; and

an elongate fillable occlusion device releasably coupled to said cannulated device and having a length of at least about 10 cm, said elongate fillable occlusion device having a proximal end and a distal end and including a wall comprising an isolated layer of a naturally-derived and non-reconstituted remodelable extracellular matrix material isolated from a biological tissue source, the isolated layer of remodelable extracellular matrix material being effective upon implantation to induce cellular invasion and ingrowth into the wall so that the wall becomes remodeled with patient tissue, wherein at least a portion of said elongate fillable occlusion device is inverted.

12. The medical product of claim 11 , wherein said cannulated device has a lumen that is in communication with an interior of said elongate occlusion device.

13. The medical product of claim 12 , wherein said elongate occlusion device comprises a compliant material.

14. The medical product of claim 12 , further comprising a wire guide positioned in the cannulated device lumen, wherein the elongate occlusion device has an opening in said wall through which the wire guide extends.

15. The medical product of claim 11 , wherein said isolated layer of remodelable extracellular matrix material retains growth factors native to said biological tissue source.

16. The medical product of claim 11 , wherein the isolated layer of remodelable extracellular matrix material comprises submucosa, renal capsule membrane, dermal collagen, dura mater, pericardium, serosa, peritoneum, or basement membrane.

17. The medical product of claim 11 , further comprising a fill material for filling an interior region of said elongate occlusion device.

18. The medical product of claim 17 , wherein the fill material comprises, collagen, chitosan, oxidized regenerated cellulose, calcium alginate, alginate, or any suitable combination thereof.

19. The medical product of claim 17 , wherein the fill material comprises a remodelable extracellular matrix fill material effective to promote ingrowth of tissue of the patient into the remodelable extracellular matrix fill material.

20. The medical product of claim 11 , wherein said elongate occlusion device has a length of at least about 20 cm.

Assignments (3)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2011
From: COOK INCORPORATED
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 027323/0827 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2008
From: PAUL, RAM H.; FLAGLE, JACOB A.; CASE, BRIAN C.
To: COOK INCORPORATED
Reel/Frame 022020/0276 →